2) ACE inhibitory activity
ACE抑制活性
1.
Soybean Bioactive Peptides(Ⅱ)——Antioxidant activity and ACE inhibitory activity of the hydrolysates;
大豆生理活性肽的研究(Ⅱ)——抗氧化性和ACE抑制活性的初步研究
2.
The properties of lactic acid bacteria with ACE inhibitory activity;
具有ACE抑制活性乳酸菌的特性研究
3.
Moreover,ACE inhibitory activity was en- hanced,its IC_(50) value was decreased from 0.
40%,回收率达到85%以上,ACE抑制活性得到提高,半抑制浓度(IC_(50))由0。
3) ACE-inhibitory activity
ACE抑制活性
1.
Physicochemical characteristics and ACE-inhibitory activity of casein non-phosphopeptides;
酪蛋白非磷肽的理化性质及ACE抑制活性
2.
Proteolytic activity of Lactobacillus helveticus was studied in this article and the ACE-inhibitory activity of the products was also researched.
本文以瑞士乳杆菌(Lactobacillushelveticus)为发酵菌种,研究了其水解乳清蛋白的能力及发酵产物的ACE抑制活性。
5) ACE inhibitory peptides
ACE抑制肽
1.
In this experiment, the ultrafiltration technology of ACE inhibitory peptides derived from fermented milk was studied.
本实验采用超滤法分离发酵乳中的ACE抑制肽,研究了超滤工艺的主要技术参数。
2.
In the present study, the ACE inhibitory peptides were prepared from whey protein with protease hydrolysis.
血管紧张素转换酶(Angiotensin-Ⅰ-converting enzyme,ACE)抑制剂具有降血压的作用,本文利用酶解法从乳清蛋白中制备ACE抑制肽。
3.
In China, there was no study on the production of casein-derived ACE inhibitory peptides thus far.
近年来的研究结果表明，酪蛋白除具有营养功能之外，还具有非常重要的生理功能，是生物活性肽的重要来源，其中乳源ACE抑制肽以安全性高、无副作用等优点在高血压的防治中具有十分重要的研究价值和实用价值，成为国内外科学家们研究的热点。
6) ACE inhibitory peptide
ACE抑制肽
1.
Improvement and application of an analysis method for food-derived ACE inhibitory peptides
食源性ACE抑制肽体外活性检测方法的改进及应用
2.
ACE inhibitory peptides were prepared from whey protein by composite enzyme (alcalase,trypsin) and the ACE inhibitory activity were determined in vitro by spectrophotometry assay.
采用碱性蛋白酶、胰蛋白酶水解乳清蛋白制备ACE抑制肽,通过体外检测法测定其ACE抑制率。
3.
The experimental results showed that Alcalase is the most suitable protease for producing ACE inhibitory peptide of oat bran protein; and the optimum hydrolysis conditions were determined as follows: [S]=5.
采用碱溶酸沉法制备了燕麦麸蛋白,并利用7种商业化蛋白酶对其进行酶解以考察生产ACE抑制肽的效果,结果表明Alcalase为最适用酶。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条